Effect of fetal bovine serum on erythropoietin receptor expression and viability of breast cancer cells

Saudi J Biol Sci. 2020 Feb;27(2):653-658. doi: 10.1016/j.sjbs.2019.11.032. Epub 2019 Dec 6.

Abstract

Erythropoietin receptors (EPORs) are present not only in erythrocyte precursors but also in non-hematopoietic cells including cancer cells. In this study, we determined the effect of fetal bovine serum (FBS) in culture medium on the EPOR expression and viability of the estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Using flow cytometry, we showed that the inclusion of 10% FBS in the medium increased the EPOR expressions and viabilities of MDA-MB-231 and MCF-7 cells. The MDA-MB-231 showed greater EPOR expression than MCF-7 cells, suggesting that the presence of ERs on cells is associated with poor expression of EPOR. Culture medium containing 10% FBS also caused increased number of breast cancer cells entering the synthesis phase of the cell cycle. The study also showed that rHuEPO treatment did not affect viability of breast cancer cells. In conclusion, it was shown that the inclusion of FBS in culture medium increased expression of EPOR in breast cancer cells and rHuEPO treatment had no effect on the proliferation of these cancer cells.

Keywords: CFU-e, colony forming units-erythroid; EPOR; EPOR, erythropoietin receptors; ER, estrogen receptor; FBS, fetal bovine serum; Fetal bovine serum; MCF-7 cell; MDA-MB-231 cell; MTT, 3-[4,5-dimethylthiazol-2yl]-2,5-diphenyltetrazolium bromide; rHuEPO, recombinant human erythropoietin.